Sir Elton John and Prince Harry Launch Global Coalition to Fight HIV and AIDS

RICHMOND, British Columbia, July 24, 2018 /PRNewswire/ --

bioLytical's INSTI HIV Self Test Perfect Fit for New Campaign to Reach Men 

bioLytical Laboratories [http://biolytical.com ], a world leader in rapid infectious disease tests and developer of the 1 minute INSTI HIV Self Test [https://insti.com/hiv-self-test ], commends Sir Elton John and Prince Harry, Duke of Sussex for the launch of the MenStar Coalition [http://www.menstarcoalition.org ] to engage men in new and innovative ways to break the cycle of HIV transmission.

"New, energetic and innovative solutions are needed more than ever before - and that is exactly what you are about to see from Sir Elton John and the MenStar Coalition partners," said the Duke of Sussex.

"Young people are the only age group where HIV infections are rising, not falling," warned rock star and veteran AIDS campaigner Sir Elton John as he announced the launch of the MenStar Coalition focused on testing and treating HIV infections in men at the 2018 International AIDS Conference [https://www.aids2018.org ] in Amsterdam today. "We have to do much, much more to bring men, especially younger men more fully into the fold," he insisted.

Much work has been done to protect women and girls but, "We can't solve the whole problem if we are only addressing half the situation," he said. "If we want to win this fight, if we want to end AIDS once and for all, we must make men part of the solution" and teach them to protect themselves, "not only their wives and girlfriends, their sisters, and daughters, but also critically their brothers and their sons."

The MenStar Coalition brings together seven founding partners to end the AIDS epidemic by 2030 including PEPFAR [https://www.pepfar.gov ], UNITAID [https://unitaid.org/#en ], The Global Fund [https://www.theglobalfund.org/en ], Elton John AIDS Foundation [http://newyork.ejaf.org ], Children's Investment Fund Foundation [https://ciff.org ], Johnson & Johnson [https://www.jnj.com ] and Gilead [http://www.gilead.com ].

The MenStar Coalition will invest $1.2 billion in the fight against HIV/AIDS and the group's first project is to launch a new HIV self-testing campaign [https://www.royal.uk/duke-sussex-attend-international-aids-conference-amsterdam ] aimed at young men in Kenya. "It makes sense to start the HIV self-testing campaign in Kenya as the INSTI HIV Self Test is already widely available [http://biolytical.com/biolytical-introduces-insti-hiv-self-test-to-kenyan-regulated-pharmacy-network ] and is the only test to hold all local regulatory approvals [http://biolytical.com/biolyticals-insti-hiv-self-test-receives-approval-from-kenya-ministry-of-health ] due to its superior performance [http://biolytical.com/insti-hiv-self-test-demonstrates-high-user-acceptance-in-kenya-study ] and 1 minute time to result," said Ryan Bennett, Senior Director of International Sales. "The test is on the ground, pharmacies are stocked but demand generation has been lacking in the drive to reach young men to get tested. That's the single greatest reason why this initiative is so important - to drive awareness and eventually testing."

According to an UNAIDS report [http://www.unaids.org/sites/default/files/media_asset/blind_spot_en.pdf ] , in sub-Saharan Africa, men and boys living with HIV are 20% less likely than women and girls living with HIV to know their HIV status, and 27% less likely to be accessing treatment. Despite their many social and economic advantages, men are less likely than women to seek out health care, to take an HIV test, or to initiate and adhere to HIV treatment.

Prince Harry has long campaigned for HIV awareness and is no stranger to INSTI. In 2016, the Prince made headlines by taking an INSTI HIV test [https://www.telegraph.co.uk/news/2016/07/14/prince-harry-takes-hiv-test-live-on-facebook---and-he-is-negativ ] in a Facebook Live video, in an appeal for more people to get tested. "It's amazing how quick it is," said Harry about the test; his results were negative. And then in 2017, Terrence Higgins Trust [https://www.tht.org.uk/news/terrence-higgins-trust-welcomes-prince-harry-and-meghan-markle-nottingham-world-aids-day ] welcomed Prince Harry and Meghan Markle to Nottingham Contemporary, on World AIDS Day to remember the lives lost to HIV and mark the incredible medical progress made in the fight against the virus.

The Duke of Sussex was at the Amsterdam conference as the Patron of Sentebale [http://sentebale.org ] , a charity he founded in 2006 to assist vulnerable children in Lesotho and Botswana affected by extreme poverty and HIV/AIDS. His Royal Highness and the #LetYouthLead [https://twitter.com/KensingtonRoyal/status/1021495303663431682 ] advocates discussed challenges and experiences for young people living with HIV/AIDS.

About bioLytical Laboratories Inc.

bioLytical Laboratories is a privately owned company engaged in the research, development and commercialization of rapid, point-of-care in vitro medical diagnostics using its proprietary INSTI technology platform. Today, the company markets and sells its INSTI HIV test and INSTI HIV/Syphilis Multiplex Test with a world-wide footprint of regulatory approvals including WHO Prequalification, US FDA, Health Canada and CE mark from European regulators. INSTI tests provide highly accurate test results in as little as 60 seconds translating into a compelling value proposition for patients, healthcare professionals and public health organizations. For more information, please visit http://www.biolytical.com and http://www.insti.com.

Eva Siu, Phone: 1-604-204-6784, Email: info@biolytical.com

PR Newswire

Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op.

Verstuur nu éénmalig een persbericht

Verstuur persberichten en beeldmateriaal naar redacties in binnen- en buitenland. Via het ANP-net, het internationale medianetwerk van PR Newswire of met een perslijst op maat.

Direct persbericht versturen
070 - 41 41 234